[Antiplatelet agents--problem for cardiac surgeon].
Bochenek
Andrzej
A
III Katedra i Oddział Kliniczny Kardiologii SAM, Slaskie Centrum Chorób Serca, ul. Szpitalna 2, 41-800 Zabrze. scchs@slam.katowice.pl
Wilczyński
Mirosław
M
D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use*; D003328:Coronary Thrombosis / Q000453:epidemiology / Q000517:prevention & control*; D004176:Dipyridamole / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D009203:Myocardial Infarction / Q000453:epidemiology / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D012307:Risk Factors; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D004176:Dipyridamole; D013988:Ticlopidine; D001241:Aspirin